1. Introduction {#sec1-molecules-23-02104}
===============

As one of the largest families, the Asteraceae (Compositae) family contains about 1600--1700 genera and 24,000--30,000 species. Most of the Asteraceae family plants are herbs and shrubs, and have been widely used as herbal medicines since ancient times all over the world \[[@B1-molecules-23-02104]\]. *Pluchea indica* Less., belongs to *Pluchea* genus, Asteraceae family, is a 1 to 2 meters high shrub. It mainly distributes in the tropical and subtropical regions of Africa, Asia, America, Australia, and China's southern provinces. As an amphibious woody semi-mangrove plant, it plays an important role in maintaining the ecological balance in the coastal areas of Southeast Asia in China \[[@B2-molecules-23-02104]\]. As a folk medicine in Guangxi, it exhibits the function of softening hardness and dissolving lump \[[@B3-molecules-23-02104]\]. As a type of food, it possesses the activity of warming the stomach \[[@B4-molecules-23-02104]\]. Its main chemical compositions are thiophenes, quinic acids, sesquiterpenes, lignans, flavonoids, and sterols \[[@B2-molecules-23-02104]\]. Pharmacological studies have shown that the plant exhibits many pharmacological functions such as anti-inflammatory \[[@B5-molecules-23-02104]\], anti-cancer \[[@B6-molecules-23-02104]\], anti-oxidant \[[@B7-molecules-23-02104]\], anti-microbial \[[@B8-molecules-23-02104]\], and insecticidal activities \[[@B9-molecules-23-02104]\].

Through the summary of relevant literature, it is found that the pharmacodynamic material basis is not yet clear for the lack of systematic research on the plant. In the course of studying the anti-inflammatory activity of various medicinal plants, 70% EtOH extract of *P. indica* was found to possess significant in vitro anti-inflammatory bioactivity. Based on the anti-inflammatory activity on LPS-induced NO production from RAW 264.7 macrophages, a systematic chemical component study of *P. indica* aerial parts was carried out. In this paper, the isolation and identification of constituents were described as well as their inhibitory effect on the production of NO in RAW 264.7 cells induced by LPS.

2. Results and Discussion {#sec2-molecules-23-02104}
=========================

In the course of our investigation of the bioactive constituents from the 70% ethanol-water (EtOH) extract of the aerial parts of *P. indica*, four new thiophenes, named as (3′′*R*)-pluthiophenol (**1**), (3′′*R*)-pluthiophenol-4′′-acetate (**2**), 3′′-ethoxy-(3′′*S*)-pluthiophenol (**3**), 3′′-ethoxy-(3′′*S*)-pluthiophenol-4′′-acetate (**4**) ([Figure 1](#molecules-23-02104-f001){ref-type="fig"}) as well as twenty-five known compounds, 3,4-dihydroxy benzaldehyde (**5**) \[[@B10-molecules-23-02104]\], vanillin (**6**) \[[@B11-molecules-23-02104]\], 3,4-dihydroxy-5-methoxybenzaldehyde (**7**) \[[@B12-molecules-23-02104]\], syringicaldehyde (**8**) \[[@B13-molecules-23-02104]\], dibutylphthalate (**9**) \[[@B14-molecules-23-02104]\], ethyl caffeate (**10**) \[[@B15-molecules-23-02104]\], 2,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-propan-1-one (**11**) \[[@B16-molecules-23-02104]\], *trans*-coniferyl aldehyde (**12**) \[[@B17-molecules-23-02104]\], esculetin (**13**) \[[@B18-molecules-23-02104]\], *threo*-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol (**14**) \[[@B19-molecules-23-02104]\], *erythro*-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol (**15**) \[[@B20-molecules-23-02104]\], (+)-isolariciresinol (**16**) \[[@B16-molecules-23-02104],[@B21-molecules-23-02104]\], (--)-(7*S*,7′*S*,8*R*,8′*R*)-4,4′-dihydroxy-3,3′,5,5′-pentamethoxy-7,9′:7′,9-diepoxylignane (**17**) \[[@B22-molecules-23-02104],[@B23-molecules-23-02104]\], (+)-9′-isovaleryllariciresinol (**18**) \[[@B24-molecules-23-02104],[@B25-molecules-23-02104],[@B26-molecules-23-02104]\], caryolane-1,9β-diol (**19**) \[[@B27-molecules-23-02104]\], (8*R*,9*R*)-isocaryolane-8,9-diol (**20**) \[[@B28-molecules-23-02104]\], clovane-2α,9β-diol (**21**) \[[@B27-molecules-23-02104]\], valenc-1(10)-ene-8,11-diol (**22**) \[[@B2-molecules-23-02104]\], fraxinellone (**23**) \[[@B29-molecules-23-02104]\], stigmasterol (**24**) \[[@B30-molecules-23-02104]\], methyl 9-hydroxynonanoate (**25**) \[[@B31-molecules-23-02104]\], triethyl citrate (**26**) \[[@B32-molecules-23-02104]\], 9,12,13-trihydroxyoctadeca-10(*E*),15(*Z*)-dienoic acid (**27**) \[[@B33-molecules-23-02104]\], pinellic acid (**28**) \[[@B34-molecules-23-02104]\], adenosine (**29**) \[[@B35-molecules-23-02104]\] ([Figure 2](#molecules-23-02104-f002){ref-type="fig"}) were obtained.

(3′′*R*)-Pluthiophenol (**1**) was isolated as yellow oil. Its molecular formula was revealed to be C~13~H~10~O~2~S by positive ESI-Q-Orbitrap MS analysis (*m*/*z* 231.04726 \[M + H\]^+^, calcd for C~13~H~11~O~2~S, 231.04743). The characteristic absorptions in its IR spectrum suggested the presences of hydroxyl (3312 cm^−1^), thiophene ring (3105, 1448 cm^−1^), and alkynyl (2222 cm^−1^). Its ^1^H-NMR (CD~3~OD, 500 MHz) ([Table 1](#molecules-23-02104-t001){ref-type="table"}) spectrum indicated the presence of one methyl \[δ 2.02 (3H, s, H~3~-5′)\], one hydroxymethyl \[δ 3.64 (1H, dd, *J* = 7.0, 11.5 Hz), 3.68 (1H, dd, *J* = 5.0, 11.5 Hz), H~2~-4′′\], one oxygenated methine \[δ 4.55 (1H, dd, *J* = 5.0, 7.0 Hz, H-3′′)\], and a couple of olefinic protons \[δ 7.08 (1H, d, *J* = 4.0 Hz, H-4), 7.15 (1H, d, *J* = 4.0 Hz, H-3)\]. The four carbon signals \[δ 124.6 (C-2), 125.9 (C-5), 133.3 (C-4), 134.9 (C-3)\] in the low field area of ^13^C-NMR (CD~3~OD, 125 MHz) spectrum, combining with the special coupling constant (*J*~H-3,4~ = 4.0 Hz) and MS data confirmed the existence of the thiophene ring. The ^1^H-^1^H COSY spectrum of **1** indicated the presence of two partial structures written in bold lines as shown in [Figure 3](#molecules-23-02104-f003){ref-type="fig"}. Furthermore, in the HMBC experiment, the long-range correlations were observed from δ~H~ 7.15 (H-3) to δ~C~ 66.8 (C-1′), 124.9 (C-2), 125.9 (C-5); δ~H~ 7.08 (H-4) to δ~C~ 78.1 (C-1′′), 124.9 (C-2), 125.9 (C-5); δ~H~ 2.02 (H~3~-5′) to δ~C~ 64.6 (C-3′), 80.1 (C-2′), 84.5 (C-4′); δ~H~ 4.55 (H-3′′) to δ~C~ 78.1 (C-1′′), 94.5 (C-2′′), 125.9 (C-5); δ~H~ 3.64, 3.68 (H~2~-4′′) to δ~C~ 64.6 (C-3′′), 94.5 (C-2′′). Consequently, the planar structure of **1** was determined. Finally, through the comparison of the optical rotation {$\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ + 11.4° (MeOH)} of **1** with those of (*R*)- and (*S*)-(3*E*)-2-hydroxy-2-methyl-4-\[1,8:4,5-bis(methylenedioxy)-2-naphthyl\]but-3-enyl acetate, {*R*: $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{20}$ + 22.6° (MeOH); *S*: $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{20}$ − 20.0° (MeOH)\], respectively} \[[@B36-molecules-23-02104]\], its absolute configuration was elucidated to be 3′′*R*.

(3′′*R*)-Pluthiophenol-4′′-acetate (**2**) was obtained as yellow oil with positive optical rotation $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ + 7.3° (MeOH)}. The molecular formula, C~15~H~12~O~3~S of **2** was determined from ESI-Q-Orbitrap MS (*m*/*z* 273.05781 \[M + H\]^+^, calcd for C~15~H~13~O~3~S, 273.05799) analysis, which was 42 Da more than that of **1**, suggesting that there was one more acetyl group in **2**. Meanwhile, the ^1^H-, ^13^C- ([Table 2](#molecules-23-02104-t002){ref-type="table"}, CD~3~OD) and 2D- (^1^H-^1^H COSY, HSQC) NMR spectra verified the existence of the acetyl group \[δ~H~ 2.08 (3H, s, H~3~-2′′′), δ~C~ 172.5 (C-1′′′)\]. The acetyl group was elucidated to substitute in C-4′′ by the long-range correlations observed from H-4′′ to C-1′′′ in the HMBC experiment. Similarly, according to the optical rotation, the absolute configuration of **2** was determined to be 3′′*R* \[[@B36-molecules-23-02104]\], and its structure was determined to be (3′′*R*)-pluthiophenol-4′′-acetate.

The planar structures of **1** and **2** had been reported by Bitew et al. \[[@B37-molecules-23-02104]\], while their absolute configurations were not being determined. Here, they were clarified by the comparison of optical rotation with those of known compounds \[[@B36-molecules-23-02104]\] for the first time.

3′′-Ethoxy-(3′′*S*)-pluthiophenol (**3**), yellow oil, the molecular formula, C~15~H~14~O~2~S (*m*/*z* 259.07875 \[M + H\]^+^, calcd for C~15~H~15~O~2~S, 259.07873) was determined by ESI-Q-Orbitrap MS. Except for the similar aglycone with **1** indicated by its ^1^H- and ^13^C-NMR ([Table 3](#molecules-23-02104-t003){ref-type="table"}) spectra, there was one more ethoxy signal \[δ 1.24 (3H, t like, *ca. J* = 7 Hz, H~3~-6′′), 3.55, 3.83 (1H each, both dq, *J* = 7.0, 9.0 Hz, H~2~-5′′)\] in **3**. The ethoxy was clarified to link to C-3′′ position by the long-range correlation observed from δ~H~ 3.55, 3.83 (H~2~-5′′) to δ~C~ 15.5 (C-6′′), 72.7 (C-3′′). At last, its absolute configuration was elucidated to be 3′′*S* by the optical rotation {$\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ − 16.7° (MeOH)} determination \[[@B36-molecules-23-02104]\].

3′′-Ethoxy-(3′′*S*)-pluthiophenol-4′′-acetate (**4**) was isolated as yellow oil. The ESI-Q-Orbitrap MS {*m*/*z* 301.08969 \[M + H\]^+^ (calcd for C~17~H~17~O~3~S, 301.08929)} and ^1^H-, ^13^C- ([Table 4](#molecules-23-02104-t004){ref-type="table"}, CD~3~OD), 2D- (^1^H-^1^H COSY, HSQC, HMBC) NMR experiments suggested that there was one more acetyl group \[δ~H~ 2.07 (3H, s, H~3~-2′′′), δ~C~ 172.3 (C-1′′′)\] at C-4′′ of aglycone than **3**. Finally, comparing the optical rotation {$\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ − 8.9° (MeOH)} with reference \[[@B36-molecules-23-02104]\], the absolute configuration of **4** was revealed to be 3′′*S*. Thus, its structure was determined as 3′′-ethoxy-(3′′*S*)-pluthiophenol-4′′-acetate.

The structures of known compounds **5**--**29** were identified by comparing their ^1^H-, ^13^C-NMR data with references.

The potential *in vitro* anti-inflammatory effects of 70% EtOH extract (PI) and 95% EtOH eluent (PIE) and compounds **1**--**29** obtained from the aerial parts of *P. indica* on LPS-stimulated NO production were accomplished by pretreating RAW 264.7 macrophages cells with them for 1 h before stimulating with LPS (500 ng/mL) for 24 h, respectively. Griess reagent (St. Louise, MO, USA) was used to measure NO concentrations in the culture medium. Comparing to unstimulated normal (negative control), NO production in LPS-stimulated RAW 264.7 macrophages was markedly induced ([Table 5](#molecules-23-02104-t005){ref-type="table"}). PI and PIE displayed potential inhibitory activities on LPS-induced NO production at 100 µg/mL. Further, using the same activity screening assay, the compounds isolated from active fractions were tested at a final concentration of 40 µM. Under this concentration, cells showed no significant influence on cell viability by dimethyl thiazolyl diphenyl tetrazolium (MTT) assay. Compared with untreated cells, the changes in cell viability were less than 10% (data not shown). As results, compounds **1**, **2**, **10**, **13**, **18**, **23** showed significant inhibitory effects at 40 µM, while **3**, **4**, **26**--**29** possessed moderate in vitro anti-inflammatory activity. These results suggested that compounds **1**, **2**, **10**, **13**, **18**, **23** may exhibit potent anti-inflammatory activity.

3. Experimental {#sec3-molecules-23-02104}
===============

3.1. General {#sec3dot1-molecules-23-02104}
------------

NMR spectra were tested on a Bruker 500 MR NMR spectrometer (Bruker BioSpin AG Industriestrasse 26 CH-8117, Fällanden, Switzerland) at 500 MHz for ^1^H- and 125 MHz for ^13^C-NMR (internal standard: TMS). Positive and negative -ion HRESI-TOF/Orbitrap-MS were determined on Thermo UHPLC-ESI-Q-Orbitrap MS spectrometer (Thermo, Waltham, MA, USA) and Agilent Technologies 6520 Accurate-Mass Q-Tof LC/MS spectrometer (Agilent Corp., Santa Clara, CA, USA). Optical rotations, UV and IR spectra were run on a Rudolph Autopol^®^ IV automatic polarimeter (l = 50 mm) (Rudolph Research Analytical, Hackettstown NJ, USA), Varian Cary 50 UV-Vis (Varian, Inc., Hubbardsdon, MA, USA) and Varian 640-IR FT-IR spectrophotometer (Varian Australia Pty Ltd., Mulgrave, Australia), respectively.

CC were performed on macroporous resin D101 (Haiguang Chemical Co., Ltd., Tianjin, China), Silica gel (48--75 μm, Qingdao Haiyang Chemical Co., Ltd., Qingdao, China), ODS (50 μm, YMC Co., Ltd., Tokyo, Japan), and Sephadex LH-20 (Ge Healthcare Bio-Sciences, Uppsala, Sweden). Preparative high-performance liquid chromatography (Prep-HPLC) column: Cosmosil 5C~18~-MS-II (4.6 mm × 250 mm) and (20 mm i.d. × 250 mm, Nakalai Tesque, Inc., Tokyo, Japan); Wacopak Navi C~30~-5 (4.6 mm × 250 mm) and (7.5 mm × 250 mm, Wako Pure Chemical Industries) were used to separate the constituents.

3.2. Plant Material {#sec3dot2-molecules-23-02104}
-------------------

The aerial parts *of Pluchea indica* Less. were collected from Hepu city, Guangxi province, China and identified by Dr. Wei Songji (Zhuang Medical College, Guanxi University of Chinese Medicine). The voucher specimen was deposited at the Academy of traditional Chinese Medicine of Tianjin University of TCM.

3.3. Extraction and Isolation {#sec3dot3-molecules-23-02104}
-----------------------------

The dried aerial parts of *P. indica* (10.0 kg) were refluxed three times with 70% EtOH. A 70% EtOH extract (1851.0 g) was provided by evaporating the solvent under pressure. Dissolved the residue in H~2~O, and the residue was then subjected to D101 CC (H~2~O → 95% EtOH), H~2~O (1110.2 g) and 95% EtOH (224.7 g) eluent were afforded, respectively.

The 95% EtOH eluent (160.7 g) was subjected to silica gel CC \[CHCl~3~-MeOH (100:1 → 100:5, *v*/*v*) → CHCl~3~-MeOH-H~2~O (10:3:1 → 7:3:1 → 6:4:1 → 5:5:1, *v/v/v*, lower layer) → MeOH\] to yield nine fractions (Fraction 1--Fraction 9).

Fraction 2 (0.6 g) was separated by silica gel CC \[Hexane → Hexane-EtOAc (25:1 → 100:7 → 10:1, *v*/*v*) → EtOAc\], and eight fractions (Fraction 2-1--Fraction 2-8) were obtained. Fraction 2-4 (89.2 mg) was purified by pHPLC \[CH~3~CN-H~2~O (73:27, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to yield 3′′-ethoxy-(3′′*S*)-pluthiophenol-4′′-acetate (**4**, 22.8 mg) and fraxinellone (**23**, 3.5 mg).

Fraction 3 (4.2 g) was subjected to SiO~2~ gel CC \[Hexane → Hexane-EtOAc (100:1 → 100:3 → 25:1 → 20:1 → 100:7 → 10:1 → 5:1, *v*/*v*) → EtOAc\], eleven fractions (Frction 3-1--Fraction 3-11) were obtained. Fraction 3-4 (219.6 mg) was separated by pHPLC \[CH~3~CN-H~2~O (32:68, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to afford stigmasterol (**24**, 27.7 mg). Fraction 3-5 (253.9 mg) was isolated by pHPLC \[MeOH-H~2~O (85:15, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to yield (3′′*R*)-pluthiophenol-4′′-acetate (**2**, 12.3 mg) and dibutylphthalate (**9**, 18.1 mg). Fraction 3-6 (139.7 mg) was purified by pHPLC \[CH~3~CN-H~2~O (20:80, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to obtain vanillin (**6**, 7.4 mg). Fraction 3-7 (195.8 mg) was separated by pHPLC \[CH~3~CN-H~2~O (23:77, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to afford triethyl citrate (**26**, 9.6 mg). Fraction 3-8 (342.9 mg) was isolated by pHPLC \[CH~3~CN-H~2~O (23:77, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to obtain *trans*-coniferyl aldehyde (**12**, 12.3 mg). Fraction 3-10 (133.8 mg) was purified by pHPLC \[CH~3~CN-H~2~O (50:50, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to yield syringicaldehyde (**8**, 7.4 mg).

Fraction 4 (5.3 g) was isolated by ODS CC \[MeOH-H~2~O (30% → 40% → 50% → 58% → 60% → 70% → 80% → 100%, *v*/*v*)\] to afford thirteen fractions (Fraction 4-1--Fraction 4-13). Fraction 4-5 (244.9 mg) was subjected to pHPLC \[MeOH-H~2~O (43:57, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\], eight fractions (Fraction 4-5-1--Fraction 4-5-8) were obtained. Fraction 4-5-4 (40.6 mg) was further separated by pHPLC \[CH~3~CN-H~2~O (25:75, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to afford seven fractions (Fraction 4-5-4-1--Fraction 4-5-4-7). Among them, Fraction 4-5-4-5 (11.9 mg) was identified as (--)-(7*S*,7′*S*,8*R*,8′*R*)-4,4′-dihydroxy-3,3′,5,5′-pentamethoxy-7,9′:7′,9-diepoxylignane (**17**, 11.9 mg). Fraction 4-5-4-2 (6.1 mg) was purified by \[CHCl~3~-MeOH (100:3, *v*/*v*) → MeOH\] to yield *threo*-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol (**14**, 2.5 mg) and *erythro*-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol (**15**, 2.1 mg). Fraction 4-6 (405.9 mg) was isolated by pHPLC \[CH~3~CN-H~2~O (25:75, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to obtain ethyl caffeate (**10**, 41.5 mg). Fraction 4-10 (536.4 mg) was purified by pHPLC \[CH~3~CN-H~2~O (41:59, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to yield (3′′*R*)-pluthiophenol (**1**, 69.6 mg) and caryolane-1,9β-diol (**19**, 13.3 mg). Fraction 4-11 (414.0 mg) was subjected to pHPLC \[CH~3~CN-H~2~O (41:59, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\], six fractions were obtained (Fraction 4-11-1--Fraction 4-11-6). Among them, fractions 4-11-3 and 4-11-4 were elucidated as (8*R*,9*R*)-isocaryolane-8,9-diol (**20**, 16.7 mg) and (+)-9′-isovaleryllariciresinol (**18**, 14.2 mg), respectively. Fraction 4-11-2 (14.7 mg) was purified by pHPLC \[MeOH-H~2~O (75:25, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to afford clovane-2α,9β-diol (**21**, 4.8 mg). Fraction 4-11-5 (66.3 mg) was further isolated by pHPLC \[MeOH-H~2~O (65:35, *v*/*v*) + 1% HAc, Wacopak Navi C~30~-5 column\], and 3′′-ethoxy-(3′′*S*)-pluthiophenol (**3**, 9.3 mg) was yield. Fraction 4-12 (314.8 mg) was separated by pHPLC \[CH~3~CN-H~2~O (38:62, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to obtain valenc-1(10)-ene-8,11-diol (**22**, 19.8 mg).

Fraction 5 (8.0 g) was separated by Sephadex LH-20 CC \[CHCl~3~-MeOH (1:1, *v*/*v*)\] to afford four fractions (Fraction 5-1--Fraction 5-4). Fraction 5-2 (3.3 g) was isolated by ODS CC \[MeOH-H~2~O (30% → 42% → 57% → 100%, *v*/*v*)\], and ten fractions (Fraction 5-2-1--Fraction 5-2-10) were yielded. Fraction 5-2-1 (394.5 mg) was isolated by pHPLC \[MeOH-H~2~O (23:77, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to afford 3,4-dihydroxy benzaldehyde (**5**, 44.2 mg), 3,4-dihydroxy-5-methoxybenzaldehyde (**7**, 9.1 mg), 2,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-propan-1-one (**11**, 6.6 mg), and esculetin (**13**, 12.0 mg). Fraction 5-2-8 (207.7 mg) was subjected to pHPLC \[CH~3~CN-H~2~O (40:60, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\], methyl 9-hydroxynonanoate (**25**, 6.9 mg) was obtained. Fraction 5-2-9 (143.3 mg) was further purified by pHPLC \[CH~3~CN-H~2~O (41:59, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to yield (3′′*R*)-pluthiophenol (**1**, 5.5 mg), 9,12,13-trihydroxyoctadeca-10(*E*),15(*Z*)-dienoic acid (**27**, 14.1 mg) and pinellic acid (**28**, 3.6 mg).

Fraction 7 (46.1 g) was isolated by Sephadex LH-20 CC \[CHCl~3~-MeOH (1:1, *v*/*v*)\] to obtained three fractions (Fraction 7-1--Fraction 7-3). Fraction 7-2 (15.5 g) was further separated by ODS CC \[MeOH-H~2~O (30% → 40% → 50% → 60% → 70% → 100%, *v*/*v*)\], and ten fractions (Fraction 7-2-1--Fraction 7-2-10) were given. Fraction 7-2-3 (1500.0 mg) was subjected to pHPLC \[CH~3~CN-H~2~O (18:82, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to obtain eleven fractions (Fraction 7-2-3-1--Fraction 7-2-3-11). Fraction 7-2-3-1 (156.2 mg) was purified by pHPLC \[MeOH-H~2~O (15:85, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to yield adenosine (**29**, 5.3 mg). Fraction 7-2-3-7 (178.3 mg) was further isolated by pHPLC \[CH~3~CN-H~2~O (20:80, *v*/*v*) + 1% HAc, Cosmosil 5C~18~-MS-II column\] to obtain (+)-isolariciresinol (**16**, 7.4 mg).

*(3′′R)-Pluthiophenol* (**1**): Yellow oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ + 11.4° (c = 0.04, MeOH); UV *λ*~max~ (MeOH) nm (log *ε*): 209 (4.45), 235 (3.92), 246 (4.07), 319 (4.49), 340 (4.47); IR *ν*~max~ (KBr) cm^−1^: 3312, 3105, 2955, 2919, 2871, 2467, 2222, 2148, 1448, 1077, 1022, 804; ^1^H- and ^13^C-NMR data, see [Table 1](#molecules-23-02104-t001){ref-type="table"}; ESI-Q-Orbitrap MS: Positive-ion mode *m*/*z* 231.04726 \[M + H\]^+^ (calcd for C~13~H~11~O~2~S, 231.04743).

*(3′′R)-Pluthiophenol-4′′-acetate* (**2**): Yellow oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ + 7.3° (c = 0.06, MeOH); UV *λ*~max~ (MeOH) nm (log *ε*): 208 (4.54), 235 (4.01), 246 (4.16), 319 (4.58), 340 (4.56); IR *ν*~max~ (KBr) cm^−1^: 3099, 2977, 2233, 1745, 1520, 1448, 1381, 1326, 1229, 1106, 1046, 807; ^1^H- and ^13^C-NMR data, see [Table 2](#molecules-23-02104-t002){ref-type="table"}; ESI-Q-Orbitrap MS: Positive-ion mode *m*/*z* 273.05781 \[M + H\]^+^ (calcd for C~15~H~13~O~3~S, 273.05799).

*3′′-Ethoxy-(3′′S)-pluthiophenol* (**3**): Yellow oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ -- 16.7° (c = 0.06, MeOH); UV *λ*~max~ (MeOH) nm (log *ε*): 208 (4.47), 235 (3.99), 246 (4.11), 319 (4.50), 340 (4.47); IR *ν*~max~ (KBr) cm^--1^: 3439, 3097, 2975, 2931, 2876, 2231, 1447, 1376, 1327, 1118, 807; ^1^H- and ^13^C-NMR data, see [Table 3](#molecules-23-02104-t003){ref-type="table"}; ESI-Q-Orbitrap MS: Positive-ion mode *m*/*z* 259.07875 \[M + H\]^+^ (calcd for C~15~H~15~O~2~S, 259.07873).

*3′′-Ethoxy-(3′′S)-pluthiophenol-4′′-acetate* (**4**): Yellow oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ -- 8.9° (c = 0.04, MeOH); UV *λ*~max~ (MeOH) nm (log *ε*): 208 (4.72), 235 (4.18), 246 (4.34), 319 (4.76), 340 (4.73); IR *ν*~max~ (KBr) cm^−1^: 3098, 2976, 2228, 1745, 1445, 1377, 1330, 1231, 1105, 1048, 808; ^1^H- and ^13^C-NMR data, see [Table 4](#molecules-23-02104-t004){ref-type="table"}; ESI-Q-Orbitrap MS: Positive-ion mode *m*/*z* 301.08969 \[M + H\]^+^ (calcd for C~17~H~17~O~3~S, 301.08929).

3.4. In Vitro Anti-Inflammatory Assay {#sec3dot4-molecules-23-02104}
-------------------------------------

### 3.4.1. Materials {#sec3dot4dot1-molecules-23-02104}

Lipopolysaccharides (LPS) and dexamethasone (Dex) were purchased from Sigma Chemical (St. Louise, MO, USA); penicillin and streptomycin were purchased from Thermo Fisher Scientific (Waltham, MA, USA); dulbecco's modified eagle medium (DMEM) medium was purchased from HyClone (Marlborough, MA, USA); fetal bovine serum (FBS) were purchased from Biological Industries (Beit Haemek, Israel); nitric oxide fluorometric assay kit was purchased from Beyotime Biotechnology (Shanghai, China).

### 3.4.2. Cell Culture {#sec3dot4dot2-molecules-23-02104}

RAW 264.7 macrophages (IBMS, CAMS/PUMC, Beijing China) were maintained in DMEM supplemented with 10% heat-inactivated FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin in a humidified atmosphere containing 5% CO~2~ at 37 °C.

### 3.4.3. Measurement of NO Levels {#sec3dot4dot3-molecules-23-02104}

Nitrite, as a major stable product of NO, the level of it measured by Griess reagent was considered to reflect the concentration of NO in culture supernatants. Extract, eluent and compounds obtained from the aerial parts of *P. indica* were used to pretreat the cells for 1 h before stimulating with LPS (500 ng/mL) for 24 h. After incubation, each culture medium (50 µL) was mixed with an equal volume of Griess reagent. An ELISA plate reader was used to determine the nitrite levels at 540 nm, and the concentrations were calculated by referring to a NaNO~2~ standard calibration curve \[[@B38-molecules-23-02104]\].

3.5. Statistical Analysis {#sec3dot5-molecules-23-02104}
-------------------------

Values are expressed as mean ± S.D. SPSS 11.0 was used to conduct the statistics of all the grouped data. *p* \< 0.05 was considered to indicate statistical significance. One-way analysis of variance (ANOVA) and Tukey's Studentized range test were used for the evaluation of the significant differences between means and post hoc, respectively.

4. Conclusions {#sec4-molecules-23-02104}
==============

In summary, during the investigation of the chemical compositions from the aerial parts of *P. indica*, twenty-nine compounds, including four new ones, (3′′*R*)-pluthiophenol (**1**), (3′′*R*)-pluthiophenol-4′′-acetate (**2**), 3′′-ethoxy-(3′′*S*)-pluthiophenol (**3**), 3′′-ethoxy-(3′′*S*)-pluthiophenol-4′′-acetate (**4**), along with twenty-five known ones (**5**--**29**) were obtained. The structures of them were determined by means of spectroscopic methods.

Meanwhile, the potential anti-inflammatory effects of compounds **1**--**29** on LPS-stimulated NO production were examined. As a result, compounds **1**, **2**, **10**, **13**, **18**, **23** displayed significant inhibitory activities on LPS-induced NO production at 40 μM, while **3**, **4**, **26**--**29** possessed moderate inhibitory effects. These results suggested that compounds **1**, **2**, **10**, **13**, **18**, **23** may have potent anti-inflammatory activity.

**Sample Availability:** Samples of all the compounds are available from the authors.
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![The new compounds **1**--**4** obtained from the aerial parts of *P. indica*.](molecules-23-02104-g001){#molecules-23-02104-f001}

###### 

The known compounds **5**--**29** obtained from the aerial parts of *P. indica*.

![](molecules-23-02104-g002a)

![](molecules-23-02104-g002b)

![The main ^1^H-^1^H COSY and HMBC correlations of **1**--**4**.](molecules-23-02104-g003){#molecules-23-02104-f003}

molecules-23-02104-t001_Table 1

###### 

^1^H- and ^13^C-NMR data for **1** in CD~3~OD and CDCl~3~.

  No.   in CD~3~OD   in CDCl~3~                     
  ----- ------------ ---------------------- ------- ----------------------
  2     124.6        ---                    124.2   ---
  3     134.9        7.15 (d, 4.0)          133.6   7.10 (d, 4.0)
  4     133.3        7.08 (d, 4.0)          132.4   7.04 (d, 4.0)
  5     125.9        ---                    123.8   ---
  1′    66.8         ---                    66.4    ---
  2′    80.1         ---                    79.6    ---
  3′    64.6         ---                    64.1    ---
  4′    84.5         ---                    83.6    ---
  5′    4.2          2.02 (s)               4.8     2.04 (s)
  1′′   78.1         ---                    79.0    ---
  2′′   94.5         ---                    91.4    ---
  3′′   64.6         4.55 (dd, 5.0, 7.0)    63.8    4.68 (dd, 4.0, 6.0)
  4′′   66.9         3.64 (dd, 7.0, 11.5)   66.2    3.77 (dd, 6.0, 11.5)
                     3.68 (dd, 5.0, 11.5)           3.83 (dd, 4.0, 11.5)

molecules-23-02104-t002_Table 2

###### 

^1^H- and ^13^C-NMR data for **2** in CD~3~OD.

  No.   δ~C~    δ~H~ (*J* in Hz)   No.    δ~C~    δ~H~ (*J* in Hz)
  ----- ------- ------------------ ------ ------- ----------------------
  2     125.0   ---                1′′    78.5    ---
  3     135.0   7.17 (d, 4.0)      2′′    93.3    ---
  4     133.6   7.10 (d, 4.0)      3′′    61.8    4.76 (dd, 5.0, 6.5)
  5     125.5   ---                4′′    68.1    4.19 (dd, 6.5, 11.0)
  1′    67.0    ---                               4.21 (dd, 5.0, 11.0)
  2′    80.1    ---                1′′′   172.5   ---
  3′    64.7    ---                2′′′   20.7    2.08 (s)
  4′    84.6    ---                               
  5′    4.1     2.03 (s)                          

molecules-23-02104-t003_Table 3

###### 

^1^H- and ^13^C-NMR data for **3** in CD~3~OD.

  No.   δ~C~    δ~H~ (*J* in Hz)   No.   δ~C~   δ~H~ (*J* in Hz)
  ----- ------- ------------------ ----- ------ ------------------------
  2     124.8   ---                5′    4.1    2.03 (s)
  3     135.0   7.16 (d, 4.0)      1′′   79.5   ---
  4     133.6   7.10 (d, 4.0)      2′′   92.5   ---
  5     125.6   ---                3′′   72.7   4.34 (t, 5.5)
  1′    66.7    ---                4′′   65.6   3.69 (d, 5.5)
  2′    80.2    ---                5′′   66.1   3.55 (dq, 7.0, 9.0)
  3′    64.5    ---                             3.83 (dq, 7.0, 9.0)
  4′    84.6    ---                6′′   15.5   1.24 (t like, *ca.* 7)

molecules-23-02104-t004_Table 4

###### 

^1^H- and ^13^C-NMR data **4** in CD~3~OD.

  No.   δ~C~    δ~H~ (*J* in Hz)   No.    δ~C~    δ~H~ (*J* in Hz)
  ----- ------- ------------------ ------ ------- ------------------------
  2     125.2   ---                1′′    79.9    ---
  3     135.1   7.17 (d, 4.0)      2′′    91.2    ---
  4     133.9   7.12 (d, 4.0)      3′′    69.5    4.57 (dd, 4.5, 6.0)
  5     125.2   ---                4′′    66.5    4.23 (dd, 4.5, 11.5)
  1′    66.6    ---                               4.26 (dd, 6.0, 11.5)
  2′    80.3    ---                5′′    66.1    3.55 (dq, 7.0, 9.0)
  3′    64.5    ---                               3.81 (dq, 7.0, 9.0)
  4′    84.7    ---                6′′    15.4    1.24 (t like, *ca.* 7)
  5′    4.1     2.03 (s)           1′′′   172.4   ---
                                   2′′′   20.7    2.07 (s)

molecules-23-02104-t005_Table 5

###### 

Inhibitory effects of positive control, PI, PIE and compounds **1**--**29** obtained from the aerial parts of *P. indica* on NO production in RAW 264.7 macrophages.

  No.       NRC (%)             No.      NRC (%)             No.      NRC (%)
  --------- ------------------- -------- ------------------- -------- -------------------
  Normal    0.6 ± 0.4           **8**    92.6 ± 5.1          **19**   104.8 ± 1.5
  Control   100.0 ± 3.1         **9**    101.1 ± 2.2         **20**   95.1 ± 0.6
  Dex       62.2 ± 2.6 \*\*\*   **10**   77.9 ± 1.5 \*\*     **21**   101.6 ± 2.0
  PI        87.8 ± 2.0 \*\*     **11**   100.9 ± 2.8         **22**   103.8 ± 1.9
  PIE       77.9 ± 1.2 \*\*\*   **12**   94.2 ± 3.9          **23**   52.1 ± 2.3 \*\*\*
  **1**     84.5 ± 0.9 \*\*     **13**   88.5 ± 1.2 \*\*     **24**   92.5 ± 0.8
  **2**     83.4 ± 0.8 \*\*     **14**   101.7 ± 3.2         **25**   93.6 ± 1.2
  **3**     86.9 ± 1.9 \*       **15**   99.7 ± 2.3          **26**   91.1 ± 0.9 \*
  **4**     90.1 ± 0.6 \*       **16**   101.9 ± 1.4         **27**   90.3 ± 0.8 \*
  **5**     92.8 ± 0.4          **17**   101.7 ± 0.1         **28**   89.5 ± 0.9 \*
  **6**     99.6 ± 1.2          **18**   77.6 ± 1.0 \*\*\*   **29**   88.7 ± 2.2 \*
  **7**     103.9 ± 6.7                                               

Positive control: Dexamethasone (Dex). Nitrite relative concentration (NRC): percentage of control group, which set as 100%. Values represent the mean ± SD of three determinations. \* *p* \< 0.05; \*\* *p* \< 0.01; \*\*\* *p* \< 0.001 (Differences between compound-treated group and control group). N = 4. Final concentration was 100 μg/mL for PI and PIE, 40 μM for **1**--**29**, and 1 μg/mL (2.6 μM) for positive control (Dex), respectively.
